The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments - Buchanan, Robert W.; Javitt, Daniel C.; Marder, Stephen R.; Schooler, Nina R.; Gold, James M.; McMahon, Robert P.; Heresco-Levy, Uriel; Carpenter, William T. (The American journal of psychiatry, 2007)
Keywords: Adolescent; Adult; Adult and adolescent clinical studies; Biological and medical sciences; Cognition & reasoning; Cognition Disorders - diagnosis; Cognition Disorders - drug therapy; Cognition Disorders - psychology; Cycloserine - therapeutic use; Double-Blind Method; Excitatory Amino Acid Agents - therapeutic use; Female; Follow-Up Studies; Glycine - therapeutic use; Humans; Hypotheses; Male; Medical sciences; Middle Aged; Neuropsychological Tests - statistics & numerical data; Patients; Placebos; Psychiatric Status Rating Scales - statistics & numerical data; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychoses; Psychotic Disorders - drug therapy; Psychotic Disorders - psychology; Psychotropic drugs; Receptors, N-Methyl-D-Aspartate - drug effects; Receptors, N-Methyl-D-Aspartate - physiology; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - drug therapy; Schizophrenic Psychology; Severity of Illness Index; Studies; Treatment Outcome; Psychosis; Schizophrenia; Cognition; Cognitive disorder; Negative symptom